Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | Chief Technology Officer | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 173,436 |
Ending reported balance
After 2026-02-23 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 57,000 · Balance 180,882 F1: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Row 2 · 2026-02-21 · Tax withholding · Disposed 3,385 · Balance 177,497 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Row 3 · 2026-02-23 · Tax withholding · Disposed 4,061 · Balance 173,436 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.72 · Expires 2036-02-20 | Direct | 85,000 |
Reported balance
After 2026-02-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-20 · Grant · Acquired 85,000 · Balance 85,000 F3: The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3: The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 24, 2026 20:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 4,061 | $0.77 | $3,110.73 |
DisclosureSEC source: 0001899089-26-000002 · form4-02242026_080215.xml · nonDerivative · entry 3 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,436 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 20:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 3,385 | $0.72 | $2,428.40 |
DisclosureSEC source: 0001899089-26-000002 · form4-02242026_080215.xml · nonDerivative · entry 2 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,497 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 20:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001899089-26-000002 · form4-02242026_080215.xml · derivative · entry 4 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2036-02-20 F3 · derivative.exercise_date: The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 20:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 57,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001899089-26-000002 · form4-02242026_080215.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,882 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 16:49 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 190 | $1.22 | $231.80 |
DisclosureSEC source: 0001062993-25-006864 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,882 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 16:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,049 | $2.65 | $2,779.85 |
DisclosureSEC source: 0001062993-25-003496 · form4.xml · nonDerivative · entry 3 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,072 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2025 Filed Feb 25, 2025 16:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 4,061 | $2.72 | $11,045.92 |
DisclosureSEC source: 0001062993-25-003496 · form4.xml · nonDerivative · entry 2 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,121 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 16:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 56,100 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001062993-25-003496 · form4.xml · derivative · entry 4 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,100 Underlying: Common Stock · 56,100 shares Expires 2035-02-21 F3 · derivative.exercise_date: The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 16:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 38,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003496 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,182 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| October 24, 2024 Filed Oct 24, 2024 16:25 UTC | TELA Bio, Inc. TELA · Entity 7381 | PurchaseCommon Stock | 22,222 | $2.25 | $49,999.50 |
DisclosureSEC source: 0001062993-24-017929 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,082 F1 · kind: The shares were purchased in the Issuer's underwritten public offering that closed on October 24, 2024, at the public offering price of $2.25 per share. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 19:44 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 190 | $5.67 | $1,077.30 |
DisclosureSEC source: 0001062993-24-007841 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,860 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,049 | $7.07 | $7,416.43 |
DisclosureSEC source: 0001062993-24-004576 · form4.xml · nonDerivative · entry 3 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,050 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 24,400 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001062993-24-004576 · form4.xml · derivative · entry 4 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 2,577 | $7.07 | $18,219.39 |
DisclosureSEC source: 0001062993-24-004576 · form4.xml · nonDerivative · entry 2 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,099 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 16:35 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 16,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004576 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,676 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 18:01 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 187 | $10.64 | $1,989.68 |
DisclosureSEC source: 0001062993-23-008665 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,976 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 19:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,032 | $11.03 | $11,382.96 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 3 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,163 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $10.50 | $0.00 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · derivative · entry 4 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,400 Underlying: Common Stock · 26,400 shares Expires 2033-02-23 F3 · derivative.exercise_date: The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,067 | $10.50 | $11,203.50 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 2 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,195 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 19:18 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 16,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005026 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,262 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 16:45 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 185 | $11.63 | $2,151.55 |
DisclosureSEC source: 0001062993-22-009232 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,462 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:24 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,023 | $11.98 | $12,255.54 |
DisclosureSEC source: 0001062993-22-005914 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,647 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 20,900 | $0.00 Strike: $11.75 | $0.00 |
DisclosureSEC source: 0001062993-22-005778 · form4.xml · derivative · entry 2 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,900 Underlying: Common Stock · 20,900 shares Expires 2032-02-23 F2 · derivative.exercise_date: The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 17:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 12,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005778 · form4.xml · nonDerivative · entry 1 Talmo Paul · CIK 0001899089 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,670 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.